Prices of cancer drugs increase “substantially” after they are launched in the United States, according to researchers.
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...
Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.
Prescription rates increased from 2021 to 2023, but high variance seen between hospitals in the rate of prescriptions ...
(HealthDay News) — Younger age at diagnosis of type 2 diabetes is significantly associated with a higher risk for subsequent dementia, according to a study published online in PLOS ONE.
Pre-operative fractionated stereotactic radiotherapy (FSRT) “compares favorably” to post-operative FSRT, according to researchers.
Risk for all-cause mortality and MACEs are affected by calcified and low-attenuation plaque burdens in patients with chronic kidney disease.
These 8 factors reversely associated with the age-standardized incidence rates of ischemic heart disease, stroke ...
(HealthDay News) — President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation’s largest medical ...
Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals ...
Tolvaptan efficacy was assessed among younger adults 18-35 years with autosomal dominant polycystic kidney disease (ADPKD), who are at high risk for progression.
More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change. (HealthDay News) — The Biden administration is proposing Medicare and Medicaid ...